Lynozyfic received FDA accelerated approval for relapsed/refractory multiple myeloma, showing a 70% response rate in trials, but carries a boxed warning for severe side effects. CAR T-cell therapy is ...

Researchers at the Fred Hutchinson Cancer Research Center found that autoantibodies targeting the exoproteome reshaped checkpoint inhibitor responses and opened new avenues to enhance immunotherapy.

(WSET) — Sinclair Cares is partnering with the American Cancer Society to help drive out cancer. There are multiple resources and programs that help cancer patients. Every person touched by cancer is ...

“Winning the war on cancer” (July 19th) was a welcome and thoughtful overview, highlighting the tangible benefits of cancer prevention and even daring to address the frontier science of personalised ...

Recent FDA approvals and clinical trial progress are accelerating lung cancer treatment advancements, focusing on personalized approaches. Datroway and Zegfrovy have been approved for specific EGFR ...